tiprankstipranks
Trending News
More News >
ImmuPharma PLC (GB:IMM)
LSE:IMM
UK Market

ImmuPharma (IMM) Financial Statements

Compare
28 Followers

ImmuPharma Financial Overview

ImmuPharma's market cap is currently £31.97M. The company's EPS TTM is p-0.004; its P/E ratio is -7.15; ImmuPharma is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue£ 0.00£ 0.00£ 0.00£ 118.35K£ 126.67K
Gross Profit£ -63.88K£ -37.61K£ -118.00K£ 118.35K£ 126.67K
Operating Income£ -2.28M£ -3.06M£ -3.03M£ -6.59M£ -5.59M
EBITDA£ -2.61M£ -3.02M£ -2.91M£ -8.70M£ -6.84M
Net Income£ -2.48M£ -2.92M£ -3.81M£ -8.17M£ -6.86M
Balance Sheet
Cash & Short-Term Investments£ 236.90K£ 208.48K£ 667.81K£ 1.65M£ 5.86M
Total Assets£ 977.01K£ 2.72M£ 3.97M£ 6.00M£ 10.92M
Total Debt£ 0.00£ 0.00£ 111.00£ 700.00£ 641.84K
Net Debt£ -236.90K£ -208.48K£ -667.70K£ -1.65M£ -5.22M
Total Liabilities£ 1.52M£ 1.67M£ 1.45M£ 1.58M£ 1.26M
Stockholders' Equity£ -542.86K£ 1.06M£ 2.52M£ 4.41M£ 9.65M
Cash Flow
Free Cash Flow£ -1.77M£ -1.36M£ -2.45M£ -4.88M£ -3.69M
Operating Cash Flow£ -1.77M£ -1.36M£ -2.35M£ -4.83M£ -3.33M
Investing Cash Flow£ 1.29M£ 188.76K£ -77.42K£ -50.28K£ -569.20K
Financing Cash Flow£ 500.02K£ 722.10K£ 1.55M£ 702.05K£ 8.37M
Currency in GBP

ImmuPharma Earnings and Revenue History

ImmuPharma Debt to Assets

ImmuPharma Cash Flow

ImmuPharma Forecast EPS vs Actual EPS